Journals / Journal of Neurological Sciences (Turkish) / 2009 / Cilt: 26 - Sayı: 1

Küme başağrısında glukokortikoid tedavi sırasında gelişen santral seröz korioretinopati

Central serous chorioretinopathy during glucocorticoid therapy for cluster headache

Pages
74–78
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This complication depending on the treatment of cluster headache with short period of corticosteroid application should be kept in mind and these patients should be observed carefully.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Central serous chorioretinopathy is an uncommon retinal disease.
📊
Key Findings & Data:It is often idiopathic but may also be associated with numerous pathological, conditions that require frequent corticosteroid treatment (1).
💡
Conclusion & Impact:This complication depending on the treatment of cluster headache with short period of corticosteroid application should be kept in mind and these patients should be observed carefully.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Central serous chorioretinopathy is an uncommon retinal disease. It is characterized by an accumulation of subretinal fluid at the posterior pole of the fundus and formed in an area surrounding the serous retinal detachment. It manifests generally as a visual loss or an abnormal colour vision. It is often idiopathic but may also be associated with numerous pathological, conditions that require frequent corticosteroid treatment (1). At least 200 cases of patients who developed central serous chorioretinopathy during glucocorticoid therapy have been reported in the literature. Corticosteroids (prednisone and dexamethazone) are quite useful for a rapid remission in patients with episodic cluster headache (2). In this report a case of central serous chorioretinopathy developed after the treatment of cluster headache period with corticosteroids is presented. This complication depending on the treatment of cluster headache with short period of corticosteroid application should be kept in mind and these patients should be observed carefully.

Özet

Santral seröz retinopati nadir görülen bir retinal hastalıktır. Fundusun posterior polünde subretinal sıvının akümülasyonu ile karakterizedir ve seröz retinal dekolmanın etrafındaki alanda oluşur. Genellikle visüel kayıp veya renkli görmede anormallik ile kendini gösterir. Sıklıkla idiopatiktir fakat kortikosteroid tedavi gerektiren ciddi patolojik durumlarla da birlikte olabilir (1). Literatürde yaklaşık 200 olguda kortikosteroid kullanımına bağlı santral seröz korioretinopati bildirilmiştir. Kortikosteroidler (prednison ve deksametason) küme başağrısı periodunda hızlı remisyon için kullanılmaktadır (2). Bu bildiride, küme periodu sırasında kortikosteroid tedavisi alan ve santral seröz korioretinopati gelişen bir olgu sunulmuştur. Küme başağrısında kısa süreli kortikosteroid kullanımına bağlı olarak bu komplikasyonun gelişebileceği akılda tutulmalı, hastalar bu yönden de yakından izlenmelidir.

🔖

Cite This Article

KOÇYİĞİT, F., ÖNER, H., ÖZTÜRK, V., UĞUREL, B. (2022). Küme başağrısında glukokortikoid tedavi sırasında gelişen santral seröz korioretinopati. Journal of Neurological Sciences (Turkish), Cilt: 26 - Sayı: 1, 74–78. https://ajindex.com/articles/565502

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Bouyon A, Costedoat-Chalumeau N, Limal N et al. Central serous chorioretinopathy and systemic diseases report of 2 cases associated with corticotherapy. Rev Med Interne 2006; 27(6):487-91
  2. Bouzas EA, Karadimas P, Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. 2002;47(5):431-48. Comment in: Surv Ophthalmol-2004;49(1):128-9; author reply 129
  3. Jain IS, Singh K. Maculopathy: a corticosteroid side-effect. J All India Ophthalmol Soc 1966; 14:250–252 4) Karadimas P, Bouzas EA. Glucocorticoid use represents a risk factor for central serous chorioretinopathy: a prospective, case-control study. Graefes Arch Clin Exp Ophthalmol. 2004;242(9):800-2
  4. May A. Update on the diagnosis and management of Trigemino-Autonomic Headaches. J Neurol 2006; 253: 1525–1532 6) Wang M, Munch IC, Hasler PW, Prünte C, Larsen M. Central serous chorioretinopathy Acta Ophthalmol Scand. 2007 Jul 28